NCT05967975

Brief Summary

To determine accuracy of elastography in assessment of superficial lymph nodes response to treatment in cases of lymphoma.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2023

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

2.3 years

First QC Date

July 23, 2023

Last Update Submit

July 23, 2023

Conditions

ElastographyLymphoma

Outcome Measures

Primary Outcomes (1)

  • To determine accuracy of elastography in assessment of superficial lymph nodes response to treatment in cases of lymphoma.

    Sonoelastography is a new technique that depends on the elastic properties of soft tissues, with the idea of malignant lesions being stiffer than benign or normal tissue. It may have a dependable role in evaluation of therapeutic response in patients with lymphoma and can be used for follow up, the same way it has been used in different parts of the body, such as the breast, and thyroid. To the best of our knowledge, there are few studies concerning the role of elastography in the field of lymphoma disease.

    Average three years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients diagnosed as lymphoma , have superficial lymph nodes and not received any treatment

You may qualify if:

  • patients who are histopathologically proven as lymphoma, not receive treatment and have superficial lymphadenopathy.

You may not qualify if:

  • Lymphoma without superficial lymph nodes. 2-patients under treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lymphoma

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Kerols Refaat, Resident

    Assiut University

    PRINCIPAL INVESTIGATOR

  • Nagham Nabil, Professor

    Assiut University

    STUDY DIRECTOR

  • Abdel-Monem Sayed, Lecture

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Kero Refaat, Resident

CONTACT

+2 01110134427kerolsrefaat13@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

July 23, 2023

First Posted

August 1, 2023

Study Start

August 1, 2023

Primary Completion

November 1, 2025

Study Completion

December 1, 2025

Last Updated

August 1, 2023

Record last verified: 2023-07